MediciNova Inc (MNOV)
Healthcare
Biotechnology
1.30 $
-0.7%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns MediciNova Inc (MNOV)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 85.8% of the shares are freely tradable; institutional investors hold 11.0%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
11.0%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
2.9%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
85.8%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
0.2%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
49Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Essex Woodlands Health Ventures | 2.25 | 1,105,941 | +0.0 | 03/31/2026 |
| BlackRock Inc | 1.43 | 705,954 | +0.1 | 03/31/2026 |
| Vanguard Group Inc | 1.43 | 705,625 | +0.7 | 12/31/2025 |
| Citigroup Inc | 1.29 | 635,715 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 1.24 | 611,039 | +0.0 | 03/31/2026 |
| Geode Capital Management, LLC | 1.10 | 543,843 | +2.7 | 03/31/2026 |
| Vanguard Fiduciary Trust Co | 0.57 | 280,621 | +0.0 | 03/31/2026 |
| UBS Group AG | 0.45 | 222,200 | -1.5 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Institutional Extnd Mkt Idx Tr | 1.24 | 611,039 | +0.0 | 04/30/2026 |
| Fidelity Extended Market Index | 0.52 | 255,141 | -0.4 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.